Elevance health's 2.750% senior convertible debentures due 2042 to accrue contingent interest

Indianapolis--( business wire )--elevance health, inc. (nyse: elv) announced today that for the six-month interest period commencing on october 15, 2022, its 2.750% senior convertible debentures due 2042 (the “debentures”) will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a debenture for the ten consecutive trading days ended october 14, 2022. contingent interest, which the company has determined to be approximately $16.8123 per note, will be payable on april 15, 2023 to holders of the debentures as of the april 1, 2023 record date.
ELV Ratings Summary
ELV Quant Ranking